Physician
Urology
Dr. Fray F. Marshall, MD
|
|
Give Review
Fray F. Marshall, MD is an expert in the field of Urology. Fray Marshall is a published doctor and has 68 publications published. The lastest was: 'Posterior lumbar vein off the retrohepatic inferior vena cava: a novel anatomical variant with surgical implications.'
Publications
- Posterior lumbar vein off the retrohepatic inferior vena cava: a novel anatomical variant with surgical implications.
- Active sonic hedgehog signaling between androgen independent human prostate cancer cells and normal/benign but not cancer-associated prostate stromal cells.
- Human prostate cancer harbors the stem cell properties of bone marrow mesenchymal stem cells.
- Comparison of 12-core versus 8-core prostate biopsy: multivariate analysis of large series of US veterans.
- Re: long-term follow-up of the treatment of renal angiomyolipomas after selective arterial embolization with alcohol.
- Impact of laparoscopic inguinal hernia repair mesh on open radical retropubic prostatectomy.
- Phorbol ester phorbol-12-myristate-13-acetate induces epithelial to mesenchymal transition in human prostate cancer ARCaPE cells.
- Differential expression of the alpha2 chain of the interleukin-13 receptor in metastatic human prostate cancer ARCaPM cells.
- Progressive epithelial to mesenchymal transitions in ARCaP E prostate cancer cells during xenograft tumor formation and metastasis.
- XMRV infection in patients with prostate cancer: novel serologic assay and correlation with PCR and FISH.
- Transcription variants of the prostate-specific PrLZ gene and their interaction with 14-3-3 proteins.
- Increased low density lipoprotein and increased likelihood of positive prostate biopsy in black americans.
- Soluble factors derived from stroma activated androgen receptor phosphorylation in human prostate LNCaP cells: roles of ERK/MAP kinase.
- Coevolution of prostate cancer and bone stroma in three-dimensional coculture: implications for cancer growth and metastasis.
- The behavior of renal cell carcinoma: sex, lies and tumor size.
- Quantum dots: emerging applications in urologic oncology.
- PrLZ is expressed in normal prostate development and in human prostate cancer progression.
- Beta2-microglobulin promotes the growth of human renal cell carcinoma through the activation of the protein kinase A, cyclic AMP-responsive element-binding protein, an...
- Oxidative stress induces ADAM9 protein expression in human prostate cancer cells.
- Human beta-defensin-1, a potential chromosome 8p tumor suppressor: control of transcription and induction of apoptosis in renal cell carcinoma.
- Current trends in molecular classification of adult renal tumors.
- North American white mitochondrial haplogroups in prostate and renal cancer.
- Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors aft...
- Percutaneous cryoablation of renal tumors: limitations and uncertainties.
- Urothelial carcinoma of the renal pelvis: a clinicopathologic study of 130 cases.
- A renal mass in the setting of a nonrenal malignancy. When is a renal tumor biopsy appropriate?
- Epididymal sparing bilateral simple orchiectomy with epididymoplasty: preservation of esthetics and body image.
- The renal sinus is the principal invasive pathway: a prospective study of 100 renal cell carcinomas.
- Promoter hypermethylation profile of kidney cancer.
- Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer.
- Serum protein profiling by SELDI mass spectrometry: detection of multiple variants of serum amyloid alpha in renal cancer patients.
- The level of cadherin-6 mRNA in peripheral blood is associated with the site of metastasis and with the subsequent occurrence of metastases in renal cell carcinoma.
- Molecular classification of renal tumors by gene expression profiling.
- Identification of markers for the selection of patients undergoing renal cell carcinoma-specific immunotherapy.
- Adjuvant chemotherapy with Paclitaxel and Carboplatin in patients with advanced carcinoma of the upper urinary tract: a study by the hellenic cooperative oncology group.
- Efficiency of [18F]FDG PET in characterising renal cancer and detecting distant metastases: a comparison with CT.
- mtDNA mutations increase tumorigenicity in prostate cancer.
- A comparison of minimally invasive open and laparoscopic radical retropubic prostatectomy.
- PrLZ, a novel prostate-specific and androgen-responsive gene of the TPD52 family, amplified in chromosome 8q21.1 and overexpressed in human prostate cancer.
- Renal cell carcinoma--prognostic factors.
- Molecular epidemiology of VHL gene mutations in renal cell carcinoma patients: relation to dietary and other factors.
- Pregnancy outcome after treatment for Wilms tumor: a report from the National Wilms Tumor Study Group.
- Clinical significance of cell proliferation, microvessel density, and CD44 adhesion molecule expression in renal cell carcinoma.
- The tuberous sclerosis complex and its highly variable manifestations.
- Cancer-specific loss of beta-defensin 1 in renal and prostatic carcinomas.
- Beta defensin-1, parvalbumin, and vimentin: a panel of diagnostic immunohistochemical markers for renal tumors derived from gene expression profiling studies using cDN...
- Thrombocytosis is associated with a significant increase in the cancer specific death rate after radical nephrectomy.
- Nephrectomy followed by interferon alpha-2b compared with inteferon alpha-2b alone for metastatic renal-cell cancer.
- Laparoscopic nephron-sparing surgery for renal tumors.
- Obesity and renal cell carcinoma--a quantitative review.
- Impact of serum basic fibroblast growth factor on prognosis in human renal cell carcinoma.
- Prognostic significance of preoperative molecular serum analysis in renal cancer.
- Re: Phase II trial of sorafenib plus interferon alfa-2b as first- or second-line therapy in patients with metastatic renal cell cancer.
- Endothelin-1 promotes cell survival in renal cell carcinoma through the ET(A) receptor.
- Lymphadenectomy for renal cell carcinoma.
- Nomograms for renal cell carcinoma.
- Human prostate fibroblasts induce growth and confer castration resistance and metastatic potential in LNCaP Cells.
- In vivo molecular and cellular imaging with quantum dots.
- The utilization of Gleason grade as the primary criterion for ordering nuclear bone scan in newly diagnosed prostate cancer patients.
- Pharmacological prophylaxis of venous thromboembolism in contemporary radical retropubic prostatectomy: does concomitant pelvic lymphadenectomy matter?
- Cytoreductive nephrectomy in metastatic renal cell carcinoma.
- Loss of HOXC6 expression induces apoptosis in prostate cancer cells.
- Receptor activator of NF-kappaB Ligand (RANKL) expression is associated with epithelial to mesenchymal transition in human prostate cancer cells.
- The value of digital rectal examination as a predictor of prostate cancer diagnosis among United States Veterans referred for prostate biopsy.
- Matched pairs of human prostate stromal cells display differential tropic effects on LNCaP prostate cancer cells.
- Vascular endothelial growth factor regulates myeloid cell leukemia-1 expression through neuropilin-1-dependent activation of c-MET signaling in human prostate cancer c...
- Expression of C-reactive protein and cyclooxygenase enzyme-2 in clear cell renal cell carcinoma: correlation with pathological parameters in 110 patients.
Schools
University Of Virginia School Of Medicine
Mass Gen Hospital
University Of Mi Hosps and Health Ctrs
Doctors Specialties
- Urology
Accepted Insurances
Education
-
Massachusetts General Hospital -
University of Michigan Hospitals and Health Centers
Hospital
-
Emory University Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Thomas L. Jarrett, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bradley S. McCowan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Zaneta D. Romain, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Paul Alphonse Jr., MD |
|
|
Dr. William J. Morton, MD |
|
|
Dr. Milton J. Deitch, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph K. Wheatley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles A. Lorentz, MD |